Douglas L Packer
Overview
Explore the profile of Douglas L Packer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
245
Citations
9217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Verma A, Haines D, Boersma L, Sood N, Natale A, Marchlinski F, et al.
Circulation
. 2023 Mar;
147(19):1422-1432.
PMID: 36877118
Background: Pulsed field ablation uses electrical pulses to cause nonthermal irreversible electroporation and induce cardiac cell death. Pulsed field ablation may have effectiveness comparable to traditional catheter ablation while preventing...
12.
Zeitler E, Li Y, Silverstein A, Russo A, Poole J, Daniels M, et al.
J Am Heart Assoc
. 2023 Jan;
12(3):e027871.
PMID: 36688367
Background Women with atrial fibrillation (AF) demonstrate more AF-related symptoms and worse quality of life (QOL). Whether increased use of ablation in women reduces sex-related QOL differences is unknown. Sex-related...
13.
Sarma D, Gladden J, Reeder G, Munger T, Packer D, Holmes D, et al.
JACC Cardiovasc Interv
. 2022 Nov;
15(21):e223-e224.
PMID: 36357037
No abstract available.
14.
Almakadma A, Sarma D, Hassett L, Miranda W, Alkhouli M, Reeder G, et al.
JACC Clin Electrophysiol
. 2022 Sep;
8(10):1323-1333.
PMID: 36117046
Pulmonary vein stenosis (PVS) may arise from a variety of conditions and result in major morbidity and mortality. In some patients, pharmacologic therapy may help, but more often in advanced...
15.
Packer D, Wilber D, Kapa S, Dyrda K, Nault I, Killu A, et al.
Circ Arrhythm Electrophysiol
. 2022 Jul;
15(8):e010347.
PMID: 35776711
Background: Ablation of ventricular tachycardia (VT) is limited by the inability to create penetrating lesions to reach intramyocardial origins. Intramural needle ablation using in-catheter, heated saline-enhanced radio frequency (SERF) energy...
16.
Chew D, Li Y, Cowper P, Anstrom K, Piccini J, Poole J, et al.
Circulation
. 2022 Jun;
146(7):535-547.
PMID: 35726631
Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of death, disabling stroke, serious bleeding,...
17.
Hindricks G, Packer D
Europace
. 2022 Jun;
24(Suppl 2):ii1-ii2.
PMID: 35661864
No abstract available.
18.
Monahan K, Bunch T, Mark D, Poole J, Bahnson T, Al-Khalidi H, et al.
Europace
. 2022 May;
24(9):1430-1440.
PMID: 35640922
Aims: Influence of atrial fibrillation (AF) type on outcomes seen with catheter ablation vs. drug therapy is incompletely understood. This study assesses the impact of AF type on treatment outcomes...
19.
Dickow J, Kirchhof P, Van Houten H, Sangaralingham L, Dinshaw L, Friedman P, et al.
J Am Heart Assoc
. 2022 May;
11(11):e024214.
PMID: 35621202
Background EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) demonstrated clinical benefit of early rhythm-control therapy (ERC) in patients with new-onset atrial fibrillation (AF) and concomitant cardiovascular...
20.
Chew D, Jones K, Loring Z, Black-Maier E, Noseworthy P, Exner D, et al.
Heart Rhythm O2
. 2022 Mar;
3(1):23-31.
PMID: 35243432
Background: Wait times for catheter ablation in patients with symptomatic atrial fibrillation (AF) may influence clinical outcomes. Objective: This study examined the relationship between the duration from AF diagnosis to...